Cryptococcal Meningitis: Clinical Trials

1 trial for Cryptococcal Meningitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Cryptococcal Meningitis: new trials by email Literature Review of Cryptococcal Meningitis trials Research Report on Cryptococcal Meningitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
Fluconazole, Flucytosine, lumbar punctures - Cryptococcal Meningitis, HIV
Phase 2 / Phase 3UnknownANRS, Emerging Infectious Diseases412012-05-012016-07-12

Narrower conditions

HIV Infections (1)  ·  Meningitis, Cryptococcal (1)

Broader conditions

Bacterial Infections and Mycoses (1)  ·  Blood-Borne Infections (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Fungal Infections (1)  ·  Central Nervous System Infections (1)  ·  Communicable Diseases (1)  ·  Cryptococcosis (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Meningitis (1)  ·  Meningitis, Fungal (1)  ·  Mycoses (1)

Interventions

Fluconazole (1)  ·  Flucytosine (1)  ·  Spinal Puncture (1)

Sponsors

ANRS, Emerging Infectious Diseases (1)

Countries

Burundi (1)  ·  Côte d’Ivoire (1)

Top investigators

Olivier Bouchaud, PhD (1)